JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4326
iShares US Pharmaceuticals ETF
IHE
$1.61B
| $750K | ﹤0.01% |
12,132
+5,508
| +83% | +$324K |
2014 Q1
39 quarters
|
|
4327
ProShares S&P 500 ex-Technology ETF
SPXT
$280M
| $749K | ﹤0.01% |
9,682
-8,353
| -46% | -$608K |
2023 Q1
3 quarters
|
|
|
BLDP
4328
Ballard Power Systems
BLDP
$720M
| $749K | ﹤0.01% |
202,506
+72,793
| +56% | +$259K |
2015 Q4
32 quarters
|
|
|
MLNK
4329
DELISTED
MeridianLink
MLNK
| $746K | ﹤0.01% |
30,122
+386
| +1% | +$7.49K |
2021 Q3
9 quarters
|
|
|
SGMO
4330
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $746K | ﹤0.01% |
1,373,275
-32,871
| -2% | -$15.2K |
2016 Q4
28 quarters
|
|
4331
Washington Trust Bancorp
WASH
$734M
| $743K | ﹤0.01% |
22,958
+10,990
| +92% | +$299K |
2013 Q2
42 quarters
|
|
4332
CALL
PNC Financial Services
PNC
$88.2B
| $743K | ﹤0.01% |
4,800
| – | – |
2021 Q2
10 quarters
|
|
4333
PUT
Signet Jewelers
SIG
$3.85B
| $740K | ﹤0.01% |
6,900
+5,900
| +590% | +$484K |
2023 Q1
3 quarters
|
|
4334
Global X Cloud Computing ETF
CLOU
$378M
| $738K | ﹤0.01% |
32,585
+9,965
| +44% | +$198K |
2020 Q4
12 quarters
|
|
|
ADAP
4335
DELISTED
Adaptimmune Therapeutics
ADAP
| $736K | ﹤0.01% |
928,224
-103,193
| -10% | -$58.2K |
2016 Q3
29 quarters
|
|
4336
CALL
Cadence Design Systems
CDNS
$96.8B
| $735K | ﹤0.01% |
2,700
-25,900
| -91% | -$6.67M |
2023 Q3
1 quarter
|
|
|
GTM
4337
CALL
ZoomInfo Technologies
GTM
$1.08B
| $734K | ﹤0.01% |
+39,700
| New | +$623K |
2023 Q4
0 quarters
|
|
|
CMCT
4338
Creative Media & Community Trust
CMCT
$12.2M
| $734K | ﹤0.01% |
8
| – | – |
2021 Q3
9 quarters
|
|
4339
PUT
Xerox
XRX
$397M
| $733K | ﹤0.01% |
40,000
| – | – |
2023 Q1
3 quarters
|
|
4340
AudioCodes
AUDC
$268M
| $733K | ﹤0.01% |
60,697
-857
| -1% | -$8.78K |
2018 Q3
21 quarters
|
|
4341
PUT
Autodesk
ADSK
$44.3B
| $730K | ﹤0.01% |
+3,000
| New | +$648K |
2023 Q4
0 quarters
|
|
|
TBI
4342
Trueblue
TBI
$279M
| $730K | ﹤0.01% |
47,588
-401,400
| -89% | -$5.61M |
2013 Q2
42 quarters
|
|
4343
KRONOS Worldwide
KRO
$895M
| $727K | ﹤0.01% |
73,111
-7,749
| -10% | -$62.9K |
2017 Q4
24 quarters
|
|
4344
The RealReal
REAL
$1.08B
| $725K | ﹤0.01% |
360,757
+244,934
| +211% | +$477K |
2019 Q2
18 quarters
|
|
4345
ProShares Ultra S&P500
SSO
$8.57B
| $724K | ﹤0.01% |
22,268
-7,786
| -26% | -$224K |
2022 Q4
4 quarters
|
|
4346
Cogent Biosciences
COGT
$5.38B
| $724K | ﹤0.01% |
123,194
-145,417
| -54% | -$1.11M |
2020 Q4
12 quarters
|
|
4347
ProShares S&P 500 ex-Health Care ETF
SPXV
$41.4M
| $723K | ﹤0.01% |
14,366
-3,174
| -18% | -$149K |
2023 Q1
3 quarters
|
|
4348
CALL
BridgeBio Pharma
BBIO
$13.1B
| $723K | ﹤0.01% |
+17,900
| New | +$538K |
2023 Q4
0 quarters
|
|
4349
Hingham Institution for Saving
HIFS
$632M
| $722K | ﹤0.01% |
3,712
+2,694
| +265% | +$462K |
2016 Q3
29 quarters
|
|
4350
CALL
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$113M
| $715K | ﹤0.01% |
+29,900
| New | +$664K |
2023 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.